Regulation of Prostaglandins in Periovulatory Follicles
Project Number5R01HD041592-03
Contact PI/Project LeaderFORTUNE, JOANNE E.
Awardee OrganizationCORNELL UNIVERSITY
Description
Abstract Text
DESCRIPTION (provided by applicant): The LH/FSH surge sets in motion a cascade
of events that culminates in the remarkable rupture of the follicular wall at
the apex and the subsequent release of the oocyte-cumulus complex. Despite its
critical importance to reproduction and fertility, and despite decades of
research, there are many gaps in our knowledge of the regulation of the
ovulatory process. Many regulators and pathways have been hypothesized to be
involved in mammalian ovulation, but results of previous studies have
highlighted essential roles for progesterone and prostaglandins (PGs). Cattle
provide an ideal animal model for studying the complex events of the
periovulatory period. We have validated a model for inducing periovulatory
follicular development in cattle and we now propose to use it to test
hypotheses about these two key regulators of ovulation and their receptors. In
Specific Aims 1 and 2, the timing, cellular site(s) of synthesis, biosynthetic
pathway, and hormonal regulation of the periovulatory increase in PG synthesis
will be examined. The hypothesis to be tested is that both theca and granulosa
cells respond to the preovulatory LH/FSH surge with an increase in PG
production, mediated by the surge-induced rise in progesterone, which in turn
induces PGF2a synthesis, via reduction from PGE2. In Specific Aim 3 we will
test the hypothesis that the effects of progesterone on prostaglandin
production by the periovulatory follicle are at least partially mediated
through progesterone-induced increases in oxytocin. Although PGs are essential
for ovulation, virtually nothing is known about the expression of PG receptors
during the periovulatory period. In Specific Aim 4, the temporal expression of
mRNA for PGF2alpha receptor in bovine periovulatory follicles will be
determined. The hypothesis that mRNA for the receptor is expressed coordinately
with the rise in PG synthesis and, is localized to the theca cells of the
periovulatory follicle will be tested. Specific Aim 5 is designed to test the
hypothesis that the LWFSH surge induces progesterone receptor (PR) in
follicular cells of the periovulatory follicle and that these receptors mediate
progesterone's effects on PG production. Together these experiments will
provide new knowledge about the regulation of, and relationship between, these
two essential mediators of ovulation and their receptors.
Eunice Kennedy Shriver National Institute of Child Health and Human Development
CFDA Code
865
DUNS Number
872612445
UEI
G56PUALJ3KT5
CCV3WG2JG248
D4H1NV4APKP3
ELS2M3C6V2S5
EQA8NBEN9WD5
FFAZGE9NH3M8
K6JRCJJXFET1
M8FBSLHASMT3
P4LRVQT1H4K5
PJUVN8AT5416
RT1JPM9UMGM5
ZBMGUAZYFGC4
ZMP8BDLJTUW9
Project Start Date
01-February-2002
Project End Date
31-January-2006
Budget Start Date
01-February-2004
Budget End Date
31-January-2005
Project Funding Information for 2004
Total Funding
$250,425
Direct Costs
$157,500
Indirect Costs
$92,925
Year
Funding IC
FY Total Cost by IC
2004
Eunice Kennedy Shriver National Institute of Child Health and Human Development
$250,425
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 5R01HD041592-03
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5R01HD041592-03
Patents
No Patents information available for 5R01HD041592-03
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5R01HD041592-03
Clinical Studies
No Clinical Studies information available for 5R01HD041592-03
News and More
Related News Releases
No news release information available for 5R01HD041592-03
History
No Historical information available for 5R01HD041592-03
Similar Projects
No Similar Projects information available for 5R01HD041592-03